News

Filter

Current filters:

Lyrica

1 to 9 of 98 results

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

US Appeals Court upholds Pfizer’s Lyrica patent until 2018

US Appeals Court upholds Pfizer’s Lyrica patent until 2018

07-02-2014

US pharma giant Pfizer has prevailed in protecting intellectual property for its blockbuster drug Lyrica…

LegalLyricaPatentsPfizerPharmaceuticalTeva Pharmaceutical Industries

Mixed results for Pfizer’s two Lyrica Phase IIIb studies

Mixed results for Pfizer’s two Lyrica Phase IIIb studies

21-10-2013

Pfizer has announced mixed results from two Phase IIIb studies of Lyrica capsules CV in patients with…

AnalgesiaLyricaNorth AmericaPfizerPharmaceuticalResearch

Pfizer's Lyrica equals levetiracetam in patients with partial onset seizures

22-02-2013

Global pharma behemoth Pfizer (NYSE: PFE) has announced top-line results from a Phase III study showing…

LyricaNeurologicalPfizerPharmaceuticalResearch

Pfizer's Lyrica misses primary endpoint in seizure frequency trial; positive in fibromyalgia

20-11-2012

US pharma behemoth Pfizer (NYSE: PFE) revealed disappointing top-line results of a double-blind, placebo-controlled,…

LyricaNeurologicalPfizerPharmaceuticalResearch

Australia to add Pfizer's Lyrica to PBS list; call for antibiotic research incentives

18-11-2012

Australia's Health Minister Tanya Plibersek on Friday announced the government's decision to subsidize…

Asia-PacificLyricaPfizerPharmaceuticalPricingRegulationResearch

1 to 9 of 98 results

COMPANY SPOTLIGHT

Menarini

Back to top